Cardinal Health, Inc. $CAH Stake Decreased by Westpac Banking Corp

Westpac Banking Corp decreased its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 7.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,152 shares of the company’s stock after selling 2,232 shares during the quarter. Westpac Banking Corp’s holdings in Cardinal Health were worth $6,041,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CAH. Bank of New York Mellon Corp acquired a new stake in shares of Cardinal Health in the second quarter valued at $308,640,000. First Nebraska Trust Co acquired a new position in shares of Cardinal Health during the 2nd quarter worth about $20,050,000. Castlekeep Investment Advisors LLC acquired a new position in shares of Cardinal Health during the 2nd quarter worth about $1,177,000. Saudi Central Bank increased its holdings in shares of Cardinal Health by 87.8% in the 2nd quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock valued at $3,913,000 after acquiring an additional 7,702 shares during the last quarter. Finally, Nilsine Partners LLC increased its holdings in shares of Cardinal Health by 437.7% in the 2nd quarter. Nilsine Partners LLC now owns 6,049 shares of the company’s stock valued at $1,437,000 after acquiring an additional 4,924 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

NYSE:CAH opened at $272.49 on Friday. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $286.29. The firm has a market cap of $62.98 billion, a PE ratio of 35.25, a P/E/G ratio of 2.13 and a beta of 0.53. The firm has a 50 day simple moving average of $247.18 and a 200-day simple moving average of $226.54.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.94 by $0.32. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The business had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. During the same quarter last year, the firm earned $2.55 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 12.96 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s payout ratio is currently 26.65%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CAH shares. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 25th. Robert W. Baird increased their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Mizuho set a $290.00 price objective on Cardinal Health in a report on Thursday, November 5th. Barclays boosted their target price on shares of Cardinal Health from $275.00 to $320.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Evercore restated an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $290.13.

Check Out Our Latest Stock Report on CAH

About Cardinal Health

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.